retatrutide parkinson's disease trial nct semaglutide vial Compounded Semaglutide (GLP-1)-150cent The NADPARK study: A randomized

Semaglutide research protocols typically begin at 0.25mg weekly, escalating through 0.5mg, 1mg, and up to 2.4mg (obesity research dose) over 16-20 weeks

On GLP-1, the appetite suppression makes the higher carb days easier to control because you are less likely to overeat even with more carbohydrates available

Retrieved from Teva

But these data gaps further underscore the need to study this population, as currently, there is "limited or no clinical guidance" on the use of GLP-1s prior to conception, the commentary authors wrote

GLP-1 agonists shouldnt be considered primary treatment for AUD, but they may provide supportive benefit alongside established therapies